Achieved Average Working Interest Fourth Quarter Production of 46,344 BOEPD Realized 2025 Adjusted EBITDA1 of $284 Million Delivered Net Cash Provided by Operating Activities of $313 Million, up 31% from 2024 Generated 2025 Funds Flow from Operations1 of $178 Million Seventh Consecutive Year of South American Reserves Growth With Over 100% Reserve Replacement PDP & 2P Achieved Company’s Best Safety Performance on Record in 2025 Subsequent to Year-End Completed a Bond Exchange, Sold Non-Core Assets and Signed an Agreement in AzerbaijanCALGARY, Alberta, March 03, 2026 (GLOBE NEWSWIRE) — Gran Tierra Energy Inc. (“Gran Tierra” or the “Company”) (NYSE American:GTE) (TSX:GTE) (LSE:GTE) today announced the Company’s financial and operating results for the fourth quarter (“the Quarter”) and year ended December 31, 2025. Gran Tierra’s...

WARRENVILLE, Ill., March 03, 2026 (GLOBE NEWSWIRE) — Fuel Tech, Inc. (NASDAQ: FTEK), a technology company using advanced engineering processes to provide emissions control systems and water treatment technologies in utility and industrial applications, today reported financial results for the fourth quarter and full year ended December 31, 2025. “2025 was a year of achievement for Fuel Tech, highlighted by a resurgence at our FUEL CHEM® operations that produced the highest annual segment revenue since 2018, a broadened opportunity landscape at our Air Pollution Control (“APC”) business segment driven in large part by the expected growth of power generation to support data center construction and operation, and measurable progress at our Dissolved Gas Infusion (“DGI”) business segment,” said Vincent J. Arnone, President and CEO....

Spin-off of biopharma operations into a public company to be called “First Tracks Biotherapeutics” on track for Q2 2026, potentially as early as late-April Phase 1b enrollment ongoing in celiac disease and trial cohort initiated in eosinophilic esophagitis for ANB033, a CD122 antagonist GSK announced strong commercial performance for Jemperli, growing >13% quarter-over-quarter to $343 million in Q4 2025, implying a ~$1.4 billion annualized run rate Expect to achieve >$390 million in annualized Jemperli royalties payable to Anaptys at GSK’s peak sales guidance of >$2.7 billion as early as 2029 Year-end 2025 cash and investments of ~$311 millionSAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today provided...

– Total net sales of $146.6 million versus $145.4 million in prior year fourth quarter –– Net income of $3.5 million versus $2.1 million in prior year fourth quarter –– EBITDA of $8.6 million versus $7.3 million in prior year fourth quarter –– Provides full-year outlook – ST. PETERSBURG, Fla., March 03, 2026 (GLOBE NEWSWIRE) — Superior Group of Companies, Inc. (NASDAQ: SGC) (the “Company”), today announced its fourth quarter 2025 results. “We finished the year with a solid fourth quarter, growing our consolidated revenues while simultaneously reducing expenses which resulted in 19% year-over-year EBITDA growth and earnings per share that nearly doubled,” said Michael Benstock, Chief Executive Officer.  “In addition, our quarterly results again demonstrated the back-end weighted nature of our business, with 6% sequential...

Delivered 9th consecutive year of profitability with net income of $76.7 million, or 10.8% margin Net Income increased 22%, or $13.9 million, compared to 2024 Generated $200 million in Cash from Operations in 2025 Paid subscribers increased over 4% to just over 3.09 million, compared to 2024  2025 revenue of $708.8 million, a less than 1% decline compared to 2024 SOUTH JORDAN, Utah, March 03, 2026 (GLOBE NEWSWIRE) — Cricut, Inc. (“Cricut”) (NASDAQ: CRCT), the creative technology company that has brought a connected platform for making to millions of users worldwide, today announced financial results for its fourth quarter and full year ended December 31, 2025. “While we are pleased with increased profitability with net income up 22%, the over 4% increase in paid subscribers, and positive machine-sell out units in both North...

Total Revenue Growth of 25.3% Year Over Year in the Fourth Quarter Same Store Sales Growth of 9.3% Year Over Year in the Fourth Quarter Opened 12 New Stores in the Fourth Quarter SCOTTSDALE, Ariz., March 03, 2026 (GLOBE NEWSWIRE) — Black Rock Coffee Bar, Inc. (Nasdaq: BRCB) (“Black Rock Coffee Bar” or the “Company”) today announced financial results for the fourth quarter ended December 31, 2025. Fourth Quarter 2025 HighlightsOpened 12 new stores during the period Total revenue of $53.6 million, up 25.3% compared to the prior year period Same Store Sales Growth(1) increased 9.3% compared to the prior year period Income (loss) from operations of $1.8 million compared to $(0.1) million in the prior year period. In the fourth quarter of 2025, income from operations margin was 3.3% Store-Level Profit(2) of $15.7 million as compared...

Significant achievements in 2025, enabling multiple near-term clinical milestones across late-stage portfolio, starting with the forthcoming topline results from DIAMOND Phase 3 trials with OCS-01 eye drops in diabetic macular edema (DME) in Q2 2026 Key expansion in neuro-ophthalmology with Breakthrough Therapy designation granted to Privosegtor, propelling the PIONEER registrational program in optic neuropathies with a potential U.S. market opportunity of over $7 billion Cash, cash equivalents, and short-term investments of $268.7 million as of December 31, 2025, providing cash runway into 2029ZUG, Switzerland, March 3, 2026 — Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (Oculis), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in ophthalmology and neuro-ophthalmology,...

Strong Fourth Quarter and Full Year Results as Latham Continued to Outperform the U.S. In-Ground Pool Market  Year-on-Year Margin Expansion Reflected Lower Cost Structure and Cost Discipline, While Increasing Investments to Drive Future Growth In February 2026, Latham Acquired Freedom Pools, Significantly Expanding Australia/New Zealand Market Position; Transaction is Expected to be Immediately Accretive to Earnings 2026 Guidance Anticipates 9.0% Net Sales Growth and 12.7% Adjusted EBITDA Growth at the MidpointsFourth Quarter 2025 Financial Highlights:Net sales of $100.0 million up 14.5% Net loss of $7.0 million / Net loss per diluted share of $0.06 vs. net loss per diluted share of $0.25 in prior year Adjusted EBITDA of $10.5 million up 189.6%, reaching 10.5% of net salesFull Year 2025 Financial Highlights:Net sales of $545.9...

HOUSTON, March 03, 2026 (GLOBE NEWSWIRE) — Orion Group Holdings, Inc. (NYSE: ORN) (the “Company” or “Orion”), a leading specialty construction company, today reported its financial results for the fourth quarter and full year ended December 31, 2025. Highlights for the year ended December 31, 2025: ($ in millions, except EPS)Revenue of $852 million, GAAP net income of $2.5 million or $0.06 per diluted share, Adjusted EBITDA of $45 million and Adjusted EPS of $0.25 per diluted share Cash flow from operations of $28 million and free cash flow of $14 million Booked awards and change orders of $763 million in the year Completed $120 million refinancing transaction materially reducing cost of borrowing Subsequent to quarter end, completed the acquisition of J.E. McAmis, strengthening jetty and breakwater marine construction capabilities Initiates...

ROLLING MEADOWS, Ill., March 03, 2026 (GLOBE NEWSWIRE) — RYTHM, Inc. (Nasdaq: RYM) (“RYTHM” or the “Company”), which delivers well-being to consumers through its portfolio of iconic brands and hemp-derived THC products including Señorita THC Margaritas, incredibles, and RYTHM Beverages, today announced financial results for the fourth quarter and full year ended December 31, 2025. Highlights for the fourth quarter ended December 31, 2025:Revenue from continuing operations of $10.7 million, up 164% from $4.0 million in the prior quarter. Gross Profit from continuing operations of $8.0 million or 75% of revenue, up from $1.4 million or 34% of revenue in the prior quarter.   Operating loss from continuing operations of $12.9 million, primarily driven by an $8.5 million non-cash impairment charge. Cash balance of $32.2 million. At...